A Study to Investigate the Effect of Single and Repeated Oral Doses of ACT-539313 on What the Body Does to Flurbiprofen, Omeprazole, Midazolam in Healthy Subjects

NCT05254548 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: ACT-539313
DRUG: Flurbiprofen
DRUG: Omeprazole
DRUG: Midazolam

Sponsor

Idorsia Pharmaceuticals Ltd.